Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFER-SLED: Albumin vs Saline for SLED in AKI
NCT03665311Phase 2Completed
- Sponsor
- Ottawa Hospital Research Institute
- Start
- Mar 2019
- Primary completion
- Jan 2020
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of albumin (human) in hypotension (2 arms), sponsored by Ottawa Hospital Research Institute. Primary endpoint: Recruitment rate at 24 months. Started Mar 2019; status: completed.
02
Drugs
albumin (human)
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT03665311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03665311.